179 related articles for article (PubMed ID: 29886583)
1. [Clinicopathologic features of primary mucosal CD30-positive T-cell lymphoproliferative disorders in head and neck region].
Liu F; Li M; Zhang LY; Guo L; Hu WW; Rao HL
Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):412-416. PubMed ID: 29886583
[No Abstract] [Full Text] [Related]
2. The spectrum of primary mucosal CD30-positive T-cell lymphoproliferative disorders of the head and neck.
Wang W; Cai Y; Sheng W; Lu H; Li X
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jan; 117(1):96-104. PubMed ID: 24332333
[TBL] [Abstract][Full Text] [Related]
3. Primary mucosal CD30-positive T-cell lymphoproliferative disorders of the head and neck rarely involving epiglottis: clinicopathological, immunohistomchemical and genetic features of a case.
Zhou J; Wang G; Zhang D; Yin Y; Pang X; Zhang J; Zhang Y; Li W
Int J Clin Exp Pathol; 2015; 8(9):11685-90. PubMed ID: 26617911
[TBL] [Abstract][Full Text] [Related]
4. Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders.
Sciallis AP; Law ME; Inwards DJ; McClure RF; Macon WR; Kurtin PJ; Dogan A; Feldman AL
Mod Pathol; 2012 Jul; 25(7):983-92. PubMed ID: 22388754
[TBL] [Abstract][Full Text] [Related]
5. Pediatric oral Epstein-Barr virus associated self-remitting CD30+ lymphoproliferative disorder: A distinct entity.
Schwartz Z; Bowe RB; Coleman M; Magro CM
Ann Diagn Pathol; 2018 Dec; 37():57-61. PubMed ID: 30292067
[TBL] [Abstract][Full Text] [Related]
6. CD30-Positive Lymphoproliferative Disorders.
Nikolaenko L; Zain J; Rosen ST; Querfeld C
Cancer Treat Res; 2019; 176():249-268. PubMed ID: 30596222
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathological characteristics of natural killer cell enteropathy: report of two cases and review of literature].
Huo YJ; Zhang DD; Zhou L; Li CF; Wang GN; Zhao WG; Zhang YP; Jian XY; Huang HF; Li WC
Zhonghua Bing Li Xue Za Zhi; 2022 Feb; 51(2):108-113. PubMed ID: 35152628
[No Abstract] [Full Text] [Related]
8. [Clinicopathologic features of systemic EBV-positive T-cell lymphoproliferative disease of childhood].
Jin Y; Zhou XG; He LJ; Xie JL; Zheng YY; Zhang YN; Zhang SH
Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):600-8. PubMed ID: 20079188
[TBL] [Abstract][Full Text] [Related]
9. A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases.
Saggini A; Gulia A; Argenyi Z; Fink-Puches R; Lissia A; Magaña M; Requena L; Simonitsch I; Cerroni L
Am J Surg Pathol; 2010 Aug; 34(8):1168-75. PubMed ID: 20661014
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and pathological analysis of three cases of childhood systemic EB virus positive T-cell lymphoproliferative disease].
Wang W; Ti HJ; Nong L; Zhang S; Zhang Y; Li T
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 44(4):594-8. PubMed ID: 22898854
[TBL] [Abstract][Full Text] [Related]
11. The spectrum of CD30+ T cell lymphoproliferative disorders in the skin.
Kartan S; Johnson WT; Sokol K; Alpdogan O; Gru AA; Nikbakht N; Porcu P
Chin Clin Oncol; 2019 Feb; 8(1):3. PubMed ID: 30691273
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathologic features of systemic EBV-positive T/NK-cell lymphoproliferative disease in adults].
Zheng XD; Zhou XG; Jin Y; Xie JL; Wei XJ; Chen SY; Mei X; Gong LP; Lü BB
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):227-34. PubMed ID: 21615995
[TBL] [Abstract][Full Text] [Related]
13. CD30/Ki-1-positive lymphoproliferative disorders of the skin--clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group.
Paulli M; Berti E; Rosso R; Boveri E; Kindl S; Klersy C; Lazzarino M; Borroni G; Menestrina F; Santucci M
J Clin Oncol; 1995 Jun; 13(6):1343-54. PubMed ID: 7751878
[TBL] [Abstract][Full Text] [Related]
14. Self-regressing oral CD30-positive, EBV-negative, T-cell lymphoproliferative lesions. A poorly understood process highlighted by ominous clinicopathologic features and indolent behavior.
Argyris PP; Ho D; Islam MN; Khurram SA; Courville EL; Morgan S; Sundick B; Soliman M; Janakiram M; Gopalakrishnan R; Koutlas IG
Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Dec; 132(6):698-707. PubMed ID: 34526251
[TBL] [Abstract][Full Text] [Related]
15. Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype.
Kummer JA; Vermeer MH; Dukers D; Meijer CJ; Willemze R
J Invest Dermatol; 1997 Nov; 109(5):636-40. PubMed ID: 9347791
[TBL] [Abstract][Full Text] [Related]
16. CD30+ T-cell lymphoproliferative disorders.
Martin JM; Wu H; Barta SK
Chin Clin Oncol; 2019 Feb; 8(1):4. PubMed ID: 30525751
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous CD30-positive T-cell lymphoproliferative disorders-clinical and histopathologic features, differential diagnosis, and treatment.
Kempf W; Kerl K; Mitteldorf C
Semin Cutan Med Surg; 2018 Mar; 37(1):24-29. PubMed ID: 29719017
[TBL] [Abstract][Full Text] [Related]
18. CD30+ T cell enriched primary cutaneous CD4+ small/medium sized pleomorphic T cell lymphoma: A distinct variant of indolent CD4+ T cell lymphoproliferative disease.
Magro CM; Olson LC; Fulmer CG
Ann Diagn Pathol; 2017 Oct; 30():52-58. PubMed ID: 28965629
[TBL] [Abstract][Full Text] [Related]
19. [Investigation on clinicopathologic features of lymphomatoid papulosis].
Wang TT; Wang L; Zhang WY; Liao DY; Xu C; Liu WP; Li GD
Zhonghua Bing Li Xue Za Zhi; 2009 Oct; 38(10):668-72. PubMed ID: 20078970
[TBL] [Abstract][Full Text] [Related]
20. Primary cutaneous CD30 positive T-cell lymphoproliferative disorders with aberrant expression of PAX5: report of three cases.
Hagiwara M; Tomita A; Takata K; Shimoyama Y; Yoshino T; Tomita Y; Nakamura S
Pathol Int; 2012 Apr; 62(4):264-70. PubMed ID: 22449230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
